Understanding how cell recycling affects bone health
The role of autophagy in bone remodeling
This study looks at how a process that helps cells recycle their parts affects the health of bone-building cells, which could lead to better ways to keep bones strong and prevent issues like Osteogenesis Imperfecta, and it might help patients understand how to improve their bone health and avoid fractures.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Arkansas for Med Scis NIH-funded |
| Lab location | 1 site (Little Rock, United States) |
| Project ID | NIH-11042855 on NIH RePORTER |
What this research studies
This research investigates the role of autophagy, a cellular recycling process, in the health of bone-forming cells called osteoblasts. By studying how these cells maintain their function and prevent dysfunction, the research aims to uncover mechanisms that contribute to skeletal diseases like Osteogenesis Imperfecta. The approach involves creating genetically modified mice to observe the effects of altered autophagy on bone mass and strength. Patients may benefit from insights gained about improving bone health and preventing fractures.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit include individuals with skeletal diseases, particularly those with Osteogenesis Imperfecta or similar conditions affecting bone density.
Not a fit: Patients with healthy bone density and no history of skeletal diseases may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for brittle bone diseases, enhancing bone strength and reducing fracture risk.
How similar studies have performed: Other research has shown promising results in understanding the role of autophagy in various cell types, suggesting that this approach could yield valuable insights for bone health.
Where this research is happening
Little Rock, United States
- Univ of Arkansas for Med Scis — Little Rock, United States (Active)
Researchers
- Principal investigator: Onal, Melda — Univ of Arkansas for Med Scis
- Study coordinator: Onal, Melda
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.